Abstract
The use of intravenous verapamil for tachyarrhythmia in infants is widely considered contraindicated due to the perceived risk of hemodynamic collapse after administration. This article reviews the relatively limited evidence that led to this well-known contraindication and highlights the interesting process by which medical practice may evolve in the absence of persuasive science.
Similar content being viewed by others
Abbreviations
- CHF:
-
Congestive heart failure
- SVT:
-
Supraventricular tachycardia
References
Epstein ML, Kiel EA, Victoria BE (1985) Cardiac decompensation following verapamil therapy in infants with supraventricular tachycardia. Pediatrics 75:737–740
Garland JS, Berens RJ, Losek JD, Wilson AD (1985) An infant fatality following verapamil therapy for supraventricular tachycardia: cardiovascular collapse following intravenous verapamil. Pediatr Emerg Care 1:198–200
Kirk CR, Gibbs JL, Thomas R, Radley-Smith R, Qureshi SA (1987) Cardiovascular collapse after verapamil in supraventricular tachycardia. Arch Dis Child 62:1265–1282
Kugler JD, Danford DA (1996) Management of infants, children, and adolescents with paroxysmal supraventricular tachycardia. J Pediatr 129:324–338
Leitner RP, Hawker RE, Celermajer JM (1983) Intravenous verapamil in the treatment of paroxysmal supraventricular tachycardia in children. Aust Paediatr J 19:40–44
Moran AM, Colan SD (1998) Verapamil therapy in infants with hypertrophic cardiomyopathy. Cardiol Young 8:310–319
Radford D (1983) Side effects of verapamil in infants. Arch Dis Child 58:465–466
Rea RF, Hamdan M, Schomer SJ, Geraets DR (1991) Inhibitory effects of procainamide on sympathetic nerve activity in humans. Circ Res 69:501–508
Saul JP, Scott WA, Brown S, Marantz P, Acevedo V, Etheridge SP et al (2005) Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial. Circulation 112:340–3477
Shahar E, Barzilay Z, Frand M (1981) Verapamil in the treatment of paroxysmal tachycardia in infants and children. J Pediatr 98:323–325
Snyder C, Bishara J, Darling R, Lucas V (2006) Verapamil-sensitive ventricular tachycardia in an infant. Congenit Heart Dis 1:124–126
Soler-Soler J, Sagrista-Sauleda J, Cabrera A, Sauleda-Pares J, Iglesias-Berengue J, Permanyer-Miralda G et al (1979) Effect of verapamil in infants with paroxysmal supraventricular tachycardia. Circulation 59:876–879
Wetzel GT, Klitzner TS (1996) Developmental cardiac electrophysiology: recent advances in cellular physiology. Cardiovasc Res 31:E52–E60
Wetzel GT, Chen F, Klitzner TS (1991) L- and T-type calcium channels in acutely isolated neonatal and adult cardiac myocytes. Pediatr Res 30:89–94
Conflict of interest
No conflicts of interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
LaPage, M.J., Bradley, D.J. & Dick, M. Verapamil in Infants: An Exaggerated Fear?. Pediatr Cardiol 34, 1532–1534 (2013). https://doi.org/10.1007/s00246-013-0739-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-013-0739-8